Sagaliam Acquisition Corp Launches Improved IPF Formula With Vitamin C in Pill and Lozenge Form and Addition of New Slimming Neutraceutical
BAYTOWN, TX / ACCESSWIRE / May 1, 2024 / Sagaliam Acquisition Corp announced today that Virogentics, Inc., a wholly owned subsidiary of SAGA ,
Sagaliam Acquisition Corp. Announces Novation Agreement With Enzolytics, Inc.
NEW YORK, NY / ACCESSWIRE / April 26, 2024 / Sagaliam Acquisition Corp. ("SAGAU", "SAGA", SAGAR") (the "Company") announced that Sagaliam entered into a Novation Agreement with Enzolytics, Inc. (OTC P
Sagaliam Acquisition Corp.'s Nasdaq Delisting and OTC Transition
SAGALIAM ACQUISITION CORP. ANNOUNCES DELISTING OF COMMON SHARES FROM NASDAQ
New York, NY, March 07, 2024 (GLOBE NEWSWIRE) -- Sagaliam Acquisition Corp. (NASDAQ: "SAGAU", "SAGA", SAGAR") (the "Company") received a Nasdaq Hearing Withdrawal letter ("Notice") from the Listing Qualifications staff
Sagaliam Acquisition Corp. Receives Delisting Notification Letter From Nasdaq
Sagaliam Acquisition Corp. Receives Delisting Notification Letter From Nasdaq
Enzolytics Announces the Signing of the Business Combination Agreement With Sagaliam Acquisition Corp (SAGA)
COLLEGE STATION, TX / ACCESSWIRE / September 18, 2023 / Enzolytics, Inc. (OTC PINK:ENZC) (Enzolytics, Inc. announces today that it has executed the binding business combination agreement for the sale
Sagaliam Acquisition Corp Faces Nasdaq Delisting Over Non-compliance
SAGALIAM ACQUISITION CORP. ANNOUNCES EXECUTION OF DEFINITIVE BUSINESS COMBINATION AGREEMENT AND RECEIPT OF NASDAQ LISTING DELINQUENCY LETTER
SAGALIAM ACQUISITION CORP. ANNOUNCES RECEIPT OF NASDAQ LISTING DELINQUENCY LETTER AND APPOINTMENT OF INDEPENDENT DIRECTORS
New York, NY, July 28, 2023 (GLOBE NEWSWIRE) -- Sagaliam Acquisition Corp. (NASDAQ: "SAGAU", "SAGA", "SAGAR") ("we", "us", "our", or the "Company") announced today that it received a delinquency not
Enzolytics Inc. Files Supplemental Information Report on the Sale of Biogenysis, Inc. and Virogentics, Inc to Sagaliam Acquisition Corp.
COLLEGE STATION, TX / ACCESSWIRE / July 11, 2023 / Enzolytics, Inc. (OTC PINK:ENZC) (Enzolytics, Inc. ("ENZC" or the "Company") filed a Supplemental Information report today to provide additional deta
Sagaliam Acquisition Corp. Announces Amendment to Non-Binding Term Sheet With Enzolytics Inc. and Addition of New Board Members
NEW YORK, NY / ACCESSWIRE / June 30, 2023 / Sagaliam Acquisition Corp. (NASDAQ:"SAGAU", "SAGA", "SAGAR") ("we", "us", "our", or the "Company") announced today that it has amended the executed non-bind
Enzolytics, Inc. Reports Amendment to Non-Binding Term Sheet With the Special Purpose Acquisition Company Sagaliam Acquisition Corp.
Sagaliam Acquisition Regains Compliance With Nasdaq
SAGALIAM ACQUISITION CORP. REGAINS COMPLIANCE WITH NASDAQ LISTING RULE 5250(C)(1)
New York, NY, June 02, 2023 (GLOBE NEWSWIRE) -- Sagaliam Acquisition Corp. (NASDAQ: "SAGAU", "SAGA", "SAGAR") ("we", "us", "our", or the "Company") announced today that it received notice from the L
Sagaliam Acquisition Corp. Announces Resignation Of Thomas W. Neukranz As Chief Financial Officer And Director, Effective May 7, 2023
Sagaliam Acquisition Corp. (NASDAQ: "SAGAU", "SAGA", "SAGAR") ("we", "us", "our", or the "Company") announced today that Thomas W. Neukranz, its Chief Financial Officer and member of its Board of Dire
SAGALIAM ACQUISITION CORP. ANNOUNCES RESIGNATION OF THOMAS W. NEUKRANZ AS CHIEF FINANCIAL OFFICER AND DIRECTOR
New York, NY, May 11, 2023 (GLOBE NEWSWIRE) -- Sagaliam Acquisition Corp. (NASDAQ: "SAGAU", "SAGA", "SAGAR") ("we", "us", "our", or the "Company") announced today that Thomas W. Neukranz, its Chief
Sagaliam Acquisition Receives Nasdaq Notice of Delinquency to File Financial Reports
12:17 PM EDT, 04/21/2023 (MT Newswires) -- Sagaliam Acquisition Corp. (SAGAU, SAGA, SAGAR) said Friday Nasdaq sent the company a delinquency notification informing it of its non-compliance with the st
Sagaliam Acquisition Corp. Announces Receipt Of Nasdaq Listing Delinquency Letter
Sagaliam Acquisition Corp. (NASDAQ: "SAGAU", "SAGA", "SAGAR") ("we", "us", "our", or the "Company") announced today that it received a delinquency notification letter ("Notice") from the Listing Quali
SAGALIAM ACQUISITION CORP. ANNOUNCES RECEIPT OF NASDAQ LISTING DELINQUENCY LETTER
New York, NY, April 21, 2023 (GLOBE NEWSWIRE) -- Sagaliam Acquisition Corp. (NASDAQ: "SAGAU", "SAGA", "SAGAR") ("we", "us", "our", or the "Company") announced today that it received a delinquency no
Enzolytics, Inc. Announces Execution of Non-Binding Term Sheet With the Special Purpose Acquisition Company Sagaliam Acquisition Corp. and Updates the Progress on the African Project
COLLEGE STATION, TX / ACCESSWIRE / April 17, 2023 / Enzolytics, Inc. (OTC PINK:ENZC) (Enzolytics, Inc. (the "Company" or "ENZC"), a drug development biotech company, and Sagaliam Acquisition Corp. (NA
No Data